Abbott Medical Recalls Merlin PCS Software
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Abbott Medical is recalling Merlin PCS 3650 programmer Model 3330 software due to a potential software malfunction during pacemaker testing.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 28, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Abbott Medical initiated a voluntary recall of its Merlin Patient Care System (PCS) software because a software malfunction may occur during the pacing capture threshold test of a pacemaker, resulting in the programmer not successfully communicating the command to terminate the test.
Which Products Are Affected
The recall affects Merlin PCS 3650 programmer Model 3330 software, versions 25.0.1 - 28.7.1. GTIN: 05414734509725. A total of 11,182 programs are involved. The recall number is Z-2405-2026. Distribution was nationwide across all U.S. states and the District of Columbia.
What You Should Do
No specific consumer actions or contact details are provided in the recall notice. Affected users should refer to guidance from Abbott Medical regarding the software.
Why This Matters
The Class II recall addresses a software issue that could affect communication during pacemaker testing procedures in devices distributed across the United States.
Source
FDA Recall Z-2405-2026 - Abbott Medical, Sylmar, CA
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,065 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 28, 2026.
Frequently Asked Questions
Common questions about this FDA recall.